Muthumanickam S, Indhumathi T, Boomi P, Balajee R, Jeyakanthan J, Anand K, et al. In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer. J Biomol Struct Dyn. 2022;40(4):1629-38.
In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer.
By Content Specialist|2022-06-20T12:16:56+02:00June 20, 2022|2022 Publication, 2022: January to March|Comments Off on In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer.
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Correction for Kipkorir et al., “De Novo Cobalamin Biosynthesis, Transport, and Assimilation and Cobalamin-Mediated Regulation of Methionine Biosynthesis in Mycobacterium smegmatis”
Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa